Can a routine shot at the pharmacy help protect your brain?
Yes. In this large Medicare study, older adults who got both doses of the shingles vaccine (Shingrix) had a 33% lower risk of new dementia over three years than unvaccinated adults. The vaccinated group also had a 28% lower risk of Alzheimer’s disease and a 33% lower risk of vascular dementia.
The shingles vaccine is given to prevent a painful rash caused by the same virus that causes chickenpox. That virus, called varicella zoster, hides in your nerves for decades after a childhood infection. Later in life, it can wake up and cause shingles, which is often followed by long-lasting nerve pain. The newer recombinant vaccine, sold as Shingrix, has been very effective at preventing this. But researchers have noticed something extra. People who get the vaccine seem to have less dementia. This new study set out to test that idea on a very large scale.
What the data show
The researchers used Medicare records to compare two big groups of US adults aged 65 and older. One group of 502,845 people had received both doses of Shingrix. The second group of 1,005,690 people had not been vaccinated, and they were carefully matched to the first group on age, health, and other factors. The teams then followed each group for up to three years to count new cases of dementia.
The difference was clear. Vaccinated adults developed dementia at a rate of 10.45 cases per 1,000 person-years, while unvaccinated adults developed it at 15.73 cases per 1,000 person-years. That works out to about a third fewer new cases in the vaccinated group. The protection covered the two most common forms of dementia, with Alzheimer’s risk falling by 28% and vascular dementia risk falling by 33%. The pattern held up in every subgroup the researchers checked, including men and women and people with different health backgrounds.
Dr. Kumar’s Take
I find this study genuinely exciting, and I want to be honest about why and where I am cautious. The size of the effect is large, and a 33% drop in dementia would be transformative if it holds up. We have very few interventions that move the needle on dementia at all, let alone by that much. At the same time, this is an observational study, not a randomized trial. People who choose to get vaccinated tend to be more engaged with their health overall, and that habit alone is linked to better brain aging. The matching the authors did is strong, but it cannot fully erase that bias. What pushes me toward optimism is that this is now the third or fourth large study pointing in the same direction. For my patients in their 60s and 70s, the dementia signal is one more reason to seriously consider the shot, on top of the well-established benefit of avoiding shingles itself.
How the study was done
This was a retrospective cohort study, which means the researchers looked back at existing Medicare claims data rather than enrolling people and assigning treatments. They identified adults who completed the two-dose Shingrix series and then found similar unvaccinated adults to compare them with. Matching on age, sex, prior health conditions, and healthcare use helps reduce, but never fully removes, the chance that the two groups differ in ways the data cannot see. The follow-up of up to three years is long enough to detect new diagnoses but too short to know whether the protection lasts a decade or longer.
Why this might work
Researchers have a few working theories for how a shingles vaccine could protect the brain. One idea is direct. The varicella zoster virus can quietly inflame blood vessels in the brain even without causing a visible rash, and preventing those flare-ups may reduce small strokes and inflammation that fuel dementia. A second idea is broader. Shingrix is a particularly strong vaccine that revs up parts of the immune system in older adults, and a better-trained immune system may clear other harmful proteins and infections that contribute to Alzheimer’s. Both ideas are plausible and not mutually exclusive.
Practical Takeaways
- If you are 50 or older and have not had the two-dose Shingrix series, talk to your doctor or pharmacist about getting it, especially given this new brain-health signal on top of the strong shingles protection.
- If you already had the older single-dose shingles vaccine (Zostavax), ask whether you should still get Shingrix, since the newer vaccine is more effective and was the one studied here.
- Do not view this vaccine as a substitute for the basics of brain health, which still include regular exercise, good sleep, blood pressure control, hearing aids if needed, and social engagement.
- If you have a weakened immune system or a history of severe reactions to vaccines, discuss timing and safety with your doctor before scheduling the shots.
Related Studies and Research
- Shingles vaccine cuts heart attack risk nearly in half for heart disease patients
- A gentle Chinese exercise lowers blood pressure as well as brisk walking
- Eating eggs regularly linked to lower Alzheimer’s risk in older adults
- Being physically fit lowers your risk of depression and dementia
FAQs
Does this study prove the shingles vaccine prevents dementia?
Not on its own. This is a strong observational study with a very large sample, but it cannot prove cause and effect the way a randomized trial can. People who get vaccinated may also exercise more, sleep better, or have closer relationships with their doctors, and any of those factors could contribute to lower dementia rates. What this study does well is add another large, carefully matched data point to a growing body of evidence pointing in the same direction. The next step researchers want is a randomized trial designed specifically to test the brain-health question.
Is it too late to benefit if I am already in my late 70s or 80s?
The study included adults age 65 and older without an upper limit, and the protective association held up across age subgroups. That suggests there is no clear age at which the benefit disappears. The bigger limit at older ages is usually the immune response, which weakens over time, and your general health. If you are otherwise medically stable and have not had shingles or the vaccine, this study supports having the conversation with your doctor sooner rather than later. Waiting another year only narrows your window.
Are there side effects I should expect from Shingrix?
Shingrix is known for being more reactive than a typical flu shot. Many people get a sore arm, fatigue, muscle aches, headache, or low-grade fever for a day or two after each of the two doses. These reactions are usually a sign your immune system is responding strongly, and they fade on their own. Serious side effects are rare. For most older adults, the trade-off of feeling crummy for 24 to 48 hours in exchange for protection against shingles and possibly dementia is a favorable one.
Bottom Line
A Medicare study of more than 1.5 million older adults found that those who completed the two-dose Shingrix vaccine series had a 33% lower risk of developing any new dementia over three years compared with matched unvaccinated adults, with similar reductions for Alzheimer’s disease and vascular dementia. While observational data cannot replace a randomized trial, this is the largest and most carefully controlled look yet at a question that keeps producing the same answer. The shingles vaccine remains worth getting to prevent shingles, and the growing evidence on brain health makes the case stronger.
